The latest call
FetchingEnovis Corp reported on November 5, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
$27.68+0.1%Nov 13 close
Figures through October 2, 2026, from the 10-Q filed November 5, 2026
Just reported
From Enovis Corp's results release of November 5, 2026; its quarterly report has since been filed.
Actual
$558.7M
+1.8% y/y
-4.1% q/q
Guided
—
No guide given
Actual
$0.06
Guided
—
No guide given
EPS, adjusted: $0.88
Actual
$3.4M
| Measure | 3 months toOct 2, 2026 | 3 months toOct 3, 2025 | Change |
|---|---|---|---|
| Total Revenue | $558.7M | $548.9M | +1.79% |
| Profit | $3.1M | -$571.1M | +100.55% |
| Profit per share | $0.06 | -$9.99 | +100.60% |
| Free Cash Flow | $35M | $29.1M | +20.30% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Enovis Corp reported on November 5, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“Our third-quarter results reflect continued progress against our innovation-led strategy and the benefits of executing with greater alignment, accountability, and discipline,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com. Availability of Information on the Enovis Website Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Enovis Corp’s Item 2.02 8-K filed November 5, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
-81% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.